Collection of Tissue Samples for Cancer Research

Part of paid clinical trials in Sacramento, California.

Sponsor
National Cancer Institute (NCI)
Study ID
NCT00900198
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
2 Months - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biopsy — PROCEDURE
    Tissue samples will be collected for research purposes from non-surgical procedures, such percutaneous biopsies for the sole purpose of obtaining specimens or biological fluids for the protocol.

Study Details

Background: -Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection of tissue specimens. Objectives: * To obtain samples from adult and pediatric patients for research purposes from tests and procedures that are done as required by the primary research protocol(s) to which a patient is enrolled or as part of their standard-of-care treatment. * To obtain samples for research purposes from non-surgical procedures, such as percutaneous biopsies, performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Eligibility: -Adult patients (18 years of age and older) and pediatric patients (younger than 18 years of age) who are being evaluated for and/or treated for cancer at the NIH Clinical Center participating sites. Design: * This is a multicenter tissue procurement protocol with NCI as the coordinating center. * For adult patients: specimens for research purposes, as outlined in this protocol, will be obtained from tests and procedures that are done as required by the primary research protocols to which a patient is enrolled or as part of their standard-of-care treatment. Non-surgical procedures, such as percutaneous biopsies, may also be performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Tissues and biological fluids to be procured may include but are not limited to blood, serum, urine, tumor tissue, normal tissue, pleural fluid, CSF, saliva, bronchial alveolar lavage (BAL), circulating tumor cells, hair follicles, and bone marrow. These specimens will be stored with unique identifiers and used to perform only those research studies that are outlined in this protocol. * For pediatric patients: tumor biopsy/resection tissue used for pediatric preclinical model development will only be from tissue already being obtained as part of a procedure necessary for the patient s clinical care or as part of a primary research protocol; blood specimens will be collected as part of a blood collection already scheduled for the patient s clinical care or as part of the planned pre-procedure bloodwork; volumes collected will not exceed institutional research limits. * Given the risks associated with any invasive procedure, such as tumor biopsy, the procedure will be discussed in detail with the patients and their parents/guardian (as indicated), including the side effects, prior to obtaining a separate consent for each procedure. A separate consent will not be signed prior to obtaining samples by minimally invasive measures, such as venipuncture. * This study has two separate consent forms at the NIH Clinical Center: one for adult patients to donate specimens for ongoing research on assay development and studies of molecular pathways, and one for adult and age-appropriate pediatric patients to donate samples for the generation of preclinical models. The study also has consent form templates for adult and pediatric patients at participating sites to donate specimens to create preclinical models. * Patients may remain on study for the duration of their consent or completion of the planned procedure, whichever comes first.

Key Dates

Start date
Jul 6, 2006
Status verified
May 2026

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: 1/Standard
    Standard
  • Arm: 2/Standard and Preclinical Models
    Standard and Preclinical Models
  • Arm: 3/Preclinical Models
    Preclinical Models
  • Arm: 4/Preclinical Models, Pediatric
    Preclinical Models, Pediatric

Primary Outcome Measure

Collection of research samples [ Time Frame: Day of collection ]

Central Contacts

Locations (16)

FacilityCityStateZIPSite coordinators
UC DavisSacramentoCalifornia95616-
University of Colorado, DenverAuroraColorado80220-
Emory UniversityAtlantaGeorgia30322
Kathryn S Sutton, MD
404-785-1651
Indiana University - PurdueIndianapolisIndiana46202-5262
Anna Maria Storniolo, MD
317-948-7576
University of IowaIowa CityIowa52242
Stephanie Chen, MD
319-678-8462
Johns Hopkins UniversityBaltimoreMaryland21205
Nyall London, M.D. PHD
801-547-7851
National Institutes of Health Clinical CenterBethesdaMaryland20892
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
800-411-1222
University of Michigan Ann ArborAnn ArborMichigan48109-0624-
Washington University - St. LouisSt LouisMissouri63110
Roheena Panni, MD
314-362-7046
Roswell Park Cancer InstituteBuffaloNew York-
John Kane, MD
716-845-3284
Ohio State UniversityColumbusOhio43210
Jim Rocco, MD, PhD
614-685-6778
Kyle VanKoevering, MD
(614) 685-6778
University of Pittsburgh Medical CenterPittsburghPennsylvania15213-2582
Rakesh Sindhi, MD
412-692-7849
Medical University of South CarolinaCharlestonSouth Carolina29425-
University of UtahSalt Lake CityUtah84112-
University of Virginia, CharlottesvilleCharlottesvilleVirginia22903-
Fred HutchinsonSeattleWashington28104
Kelly Smith, MD PhD
206-598-7143

Find similar trials in Sacramento, CA

By condition

Related Studies